Purine Nucleosidase Phosphorylase (PNP): A novel target in leukemias and lymphomas.
Kantarjian
Hagop M
HM
Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX.
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003848:Deoxyguanine Nucleotides / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011683:Purine-Nucleoside Phosphorylase / Q000037:antagonists & inhibitors / Q000187:drug effects
D000970:Antineoplastic Agents; D003848:Deoxyguanine Nucleotides; D004791:Enzyme Inhibitors; C029603:deoxyguanosine triphosphate; D011683:Purine-Nucleoside Phosphorylase